Tezosentan disodium

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameTezosentan disodium
Drug Alias Name替唑生坦二钠TezosentanumTezosentan替唑生坦ACT-050089 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelin receptor type B antagonistsEndothelin receptor type A antagonists
TargetsEndothelin receptor type AEndothelin receptor type B
Therapy Area/IndicationsHeart FailureHeart DiseasesPulmonary Arterial Hypertension +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[21] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIdorsia Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsHeart FailureHeart DiseasesPulmonary Arterial Hypertension +[4] 

Other Information

ATC CodeN/A
Related LinksN/A